Global Variome shared LOVD
HTR3A (5-hydroxytryptamine (serotonin) receptor 3A,...)
LOVD v.3.0 Build 28d [
Current LOVD status
]
Register as submitter
|
Log in
Curator:
Beate Niesler
View all genes
View HTR3A gene homepage
View graphs about the HTR3A gene database
Create a new gene entry
View all transcripts
View all transcripts of gene HTR3A
Create a new transcript information entry
View all variants
View all variants affecting transcripts
View unique variants in gene HTR3A
View all variants in gene HTR3A
Full data view for gene HTR3A
Create a new data submission
View active genomic custom columns
Enable more genomic custom columns
View all individuals
View all individuals with variants in gene HTR3A
Create a new data submission
View active custom columns
Enable more custom columns
View all diseases
View all diseases associated with gene HTR3A
Create a new disease information entry
View available phenotype columns
View all screenings
View all screenings for gene HTR3A
Create a new data submission
View active custom columns
Enable more custom columns
Submit new data
All variants in the HTR3A gene
University of Heidelberg Serotonin receptor variant database
The variants shown are described using the NM_000869.5 transcript reference sequence.
Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect
: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon
: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA)
: description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
RNA change
: description of variant at RNA level (following HGVS recommendations).
r.123c>u
r.? = unknown
r.(?) = RNA not analysed but probably transcribed copy of DNA variant
r.spl? = RNA not analysed but variant probably affects splicing
r.(spl?) = RNA not analysed but variant may affect splicing
r.0? = change expected to abolish transcription
Protein
: description of variant at protein level (following HGVS recommendations).
p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
p.Arg345Pro = change derived from RNA analysis
p.? = unknown effect
p.0? = probably no protein produced
P-domain
: region/domain protein affected
Allele
: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Classification method
: The method used for the clinical classification of this variant.
All options:
ACMG
ACGS
EAHAD-CFDB
ENIGMA
IARC
InSiGHT
kConFab
other
Clinical classification
: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
pathogenic
pathogenic (dominant)
pathogenic (recessive)
pathogenic (!)
pathogenic (maternal)
pathogenic (paternal)
likely pathogenic
likely pathogenic (dominant)
likely pathogenic (recessive)
likely pathogenic (!)
likely pathogenic (maternal)
likely pathogenic (paternal)
VUS
VUS (!)
likely benign
likely benign (dominant)
likely benign (recessive)
likely benign (!)
likely benign (maternal)
likely benign (paternal)
benign
benign (dominant)
benign (recessive)
benign (!)
benign (maternal)
benign (paternal)
association
unclassified
NA
DNA change (genomic) (hg19)
: HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38)
: HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as
: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN
: description of the variant according to ISCN nomenclature
DB-ID
: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks
: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference
: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID
: ID of variant in ClinVar database
dbSNP ID
: the dbSNP ID
Origin
: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
Germline
De novo
Germline/De novo (untested)
Somatic
Uniparental disomy
Uniparental disomy, maternal allele
Uniparental disomy, paternal allele
CLASSIFICATION record
SUMMARY record
In vitro (cloned)
In silico
animal model
Artefact
DUPLICATE record
Unknown
Not applicable
Segregation
: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
? = unknown
yes = segregates with phenotype
no = does not segregate with phenotype
- = not applicable
Frequency
: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site
: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP
: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.
Methylation
: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)
How to query this table
All list views have search fields which can be used to search data. You can search for a complete word or you can search for a part of a search term. If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify. Note that search terms are case-insensitive and that wildcards such as * are treated as normal text! For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.
Operator
Column type
Example
Matches
Text
Arg
all entries containing 'Arg'
space
Text
Arg Ser
all entries containing 'Arg' and 'Ser'
|
Text
Arg|Ser
all entries containing 'Arg' or 'Ser'
!
Text
!fs
all entries not containing 'fs'
^
Text
^p.(Arg
all entries beginning with 'p.(Arg'
$
Text
Ser)$
all entries ending with 'Ser)'
=""
Text
=""
all entries with this field empty
=""
Text
="p.0"
all entries exactly matching 'p.0'
!=""
Text
!=""
all entries with this field not empty
!=""
Text
!="p.0"
all entries not exactly matching 'p.0?'
combination
Text
*|Ter !fs
all entries containing '*' or 'Ter' but not containing 'fs'
Date
2020
all entries matching the year 2020
|
Date
2020-03|2020-04
all entries matching March or April, 2020
!
Date
!2020-03
all entries not matching March, 2020
<
Date
<2020
all entries before the year 2020
<=
Date
<=2020-06
all entries in or before June, 2020
>
Date
>2020-06
all entries after June, 2020
>=
Date
>=2020-06-15
all entries on or after June 15th, 2020
combination
Date
2019|2020 <2020-03
all entries in 2019 or 2020, and before March, 2020
Numeric
23
all entries exactly matching 23
|
Numeric
23|24
all entries exactly matching 23 or 24
!
Numeric
!23
all entries not exactly matching 23
<
Numeric
<23
all entries lower than 23
<=
Numeric
<=23
all entries lower than, or equal to, 23
>
Numeric
>23
all entries higher than 23
>=
Numeric
>=23
all entries higher than, or equal to, 23
combination
Numeric
>=20 <30 !23
all entries with values from 20 to 29, but not equal to 23
Some more advanced examples:
Example
Matches
Asian
all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc.
Asian !Caucasian
all entries containing 'Asian' but not containing 'Caucasian'
Asian|African !Caucasian
all entries containing 'Asian' or 'African', but not containing 'Caucasian'
"South Asian"
all entries containing 'South Asian', but not containing 'South East Asian'
To sort on a certain column, click on the column header or on the arrows. If that column is already selected to sort on, the sort order will be swapped. The column currently sorted on has a darker blue background color than the other columns. The up and down arrows next to the column name indicate the current sorting direction. When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.
80 entries on 1 page. Showing entries 1 - 80.
10 per page
25 per page
50 per page
100 per page
250 per page
500 per page
1000 per page
Legend
How to query
Effect
Exon
DNA change (cDNA)
RNA change
Protein
P-domain
Classification method
Clinical classification
DNA change (genomic) (hg19)
DNA change (hg38)
Published as
ISCN
DB-ID
Variant remarks
Reference
ClinVar ID
dbSNP ID
Origin
Segregation
Frequency
Re-site
VIP
Methylation
Owner
+?/?
_1
c.-489A>G
r.(?)
p.(=)
-
-
association
g.113845541A>G
g.113974819A>G
-507A>G, -233-u256A>G
-
HTR3A_000001
-
PubMed: Windemuth 2008
-
rs1150226
Germline
-
0.15
-
-
-
Louise Amlie-Wolf
?/?
_1
c.-489A>G
r.(?)
p.(=)
-
-
VUS
g.113845541A>G
-
-
-
HTR3A_000022
-
PubMed: Ducci 2009
-
rs1150226
Germline
-
0.04-0.06
-
-
-
Louise Amlie-Wolf
-?/?
1
c.-112_-109dup
r.(?)
p.(=)
-
-
likely benign
g.113845918_113845921dup
g.113975196_113975199dup
c.-130_-129insGAAA
-
HTR3A_000002
-
PubMed: Hammer 2009
-
-
Germline
-
0.008 (0.002-0.023)
-
-
-
Louise Amlie-Wolf
?/?
1
c.-111_-110del
r.(?)
p.(=)
-
-
VUS
g.113845919_113845920del
g.113975197_113975198del
c.-130_-129del
-
HTR3A_000003
-
PubMed: Kaiser 2004
-
-
Germline
-
0.008
+BpuEI,SmlI / -BspCNI,DdeI,Hpy188I,HpyAV
-
-
Louise Amlie-Wolf
-?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
likely benign
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Kaiser 2004
-
rs1062613
Germline
-
33.9 %
-Hpy188III
-
-
Louise Amlie-Wolf
+?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
association
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Hammer 2009
-
rs1062613
Germline
-
0.186 (0.149-0.229)
-Hpy188III
-
-
Louise Amlie-Wolf
+?/+?
1
c.-24T>C
r.(?)
p.(=)
-
-
association
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Niesler 2001a
-
rs1062613
Germline
-
68/312 BP (35/312 Controls)
-Hpy188III
-
-
Louise Amlie-Wolf
-?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
likely benign
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Melke 2003
-
rs1062613
Germline
-
134/366
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Kilpatrick 2011
-
rs1062613
Germline
-
0.27
-Hpy188III
-
-
Louise Amlie-Wolf
-?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
likely benign
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Frank 2004
-
rs1062613
Germline
-
16/96 FM (35/312 Controls)
-Hpy188III
-
-
Louise Amlie-Wolf
+?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
association
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
deVires 2007 (Meeting Abstract)
-
rs1062613
Germline
-
0.19
-Hpy188III
-
-
Louise Amlie-Wolf
-?/-?
1
c.-24T>C
r.(?)
p.(=)
-
-
likely benign
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Niesler 2005
-
rs1062613
Germline
-
10/48 GTS; 26/151 Controls
-Hpy188III
-
-
Louise Amlie-Wolf
+?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
association
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
regulatory region in 5'UTR affected:2-3 times increased expression on protein level
PubMed: Kapeller 2008
-
rs1062613
Germline
-
0.150 (0.104-0.207)
-Hpy188III
-
-
Louise Amlie-Wolf
+?/+?
1
c.-24T>C
r.(?)
p.(=)
-
-
association
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Niesler 2001a
-
rs1062613
Germline
-
27/148 SZ
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Lehmann 2013
-
rs1062613
Germline
-
-
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Rajkumar 2012
-
rs1062613
Germline
-
0.08
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Gu 2015
-
rs1062613
Germline
-
0.33 cases, 0.21 controls
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Kato 2006
-
rs1062613
Germline
-
0.12
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Hammer 2012
-
rs1062613
Germline
-
0.17-0.22
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
regulatory region in 5'UTR affected:2-3 times increased expression on protein level
PubMed: Jajodia 2015
-
rs1062613
Germline
-
-
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Zhang 2013
-
rs1062613
Germline
-
-
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Sugai 2006
-
rs1062613
Germline
-
0.35
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Mujakovic 2011
-
rs1062613
Germline
-
0.22
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Gatt 2010
-
rs1062613
Germline
-
0.24
-Hpy188III
-
-
Louise Amlie-Wolf
?/?
1
c.-24T>C
r.(?)
p.(=)
-
-
VUS
g.113846006T>C
g.113975284T>C
c.-42C>T; (178 C>T, C178T)
-
HTR3A_000004
-
PubMed: Gatt 2010
-
rs1062613
Germline
-
0.24
-Hpy188III
-
-
Louise Amlie-Wolf
+/.
-
c.-24T>C
r.(?)
p.(=)
-
-
association
g.113846006T>C
g.113975284T>C
-42C>T (178C>T, C178T)
-
HTR3A_000004
-
Atanasova 2022, submitted
-
rs1062613
Germline
-
27/83 cases IBD
-
-
-
Stefanie Schmitteckert
+/.
-
c.-24T>C
r.(?)
p.(=)
-
-
association
g.113846006T>C
g.113975284T>C
-42C>T (178C>T, C178T)
-
HTR3A_000004
-
Atanasova 2022, submitted
-
rs1062613
Germline
-
54/83 cases IBD
-
-
-
Stefanie Schmitteckert
-?/-?
1
c.-7C>T
r.(?)
p.(=)
-
-
likely benign
g.113846023C>T
g.113975301C>T
c.-25C>T; (195 C>T, C195T)
-
HTR3A_000004
-
PubMed: Niesler 2001a
-
rs62625041
Germline
-
2/312 BP (1/312 Controls)
-MslI
-
-
Louise Amlie-Wolf
-?/?
8
c.(1060_1062)
r.(?)
p.(Leu354=)
LIL
-
likely benign
g.(113857672_113857674)?
-
c.? (L354L)
-
HTR3A_000017
-
PubMed: Kaiser 2004
-
-
Germline
-
0.004 (242 analysed)
-
-
-
Louise Amlie-Wolf
-?/?
7
c.?
r.(?)
p.?
N-Term
-
likely benign
g.?
-
c.?, p.M257I
-
HTR3A_000014
-
PubMed: Kaiser 2004
-
-
Germline
-
3.0%/242
-
-
-
Louise Amlie-Wolf
-?/?
1
c.48C>T
r.(?)
p.(Leu16=)
N-Term
-
likely benign
g.113846077C>T
g.113975355C>T
c.30C>T , p.L10L; (249C>T,C249T)
-
HTR3A_000005
-
PubMed: Hammer 2009
-
rs33940208
Germline
-
0.026 (0.013-0.048)
-
-
-
Louise Amlie-Wolf
-?/-?
1
c.48C>T
r.(?)
p.(Leu16=)
N-Term
-
likely benign
g.113846077C>T
g.113975355C>T
c.30C>T, p.L10L; (249C>T,C249T)
-
HTR3A_000005
-
PubMed: Niesler 2001b
-
rs33940208
Germline
-
4/312 BP( 5/312 Controls. 2/150 SZ )
-
-
-
Louise Amlie-Wolf
-?/?
1
c.48C>T
r.(?)
p.(Leu16=)
N-Term
-
likely benign
g.113846077C>T
g.113975355C>T
c.30C>T , p.L10L; (249C>T,C249T)
-
HTR3A_000005
-
PubMed: Kaiser 2004
-
rs33940208
Germline
-
2/96 FM (5/312 Controls)
-
-
-
Louise Amlie-Wolf
?/?
1
c.48C>T
r.(?)
p.(Leu16=)
N-Term
-
VUS
g.113846077C>T
g.113975355C>T
rs33940208 ; p.Leu16Leu
-
HTR3A_000005
-
PubMed: Joy Lin 2014
-
rs33940208
Germline
-
0.26
-
-
-
Louise Amlie-Wolf
?/?
1
c.48C>T
r.(?)
p.(Leu16=)
N-Term
-
VUS
g.113846077C>T
g.113975355C>T
rs33940208: NC_000011.10:g.113975355C>T, NC_000011.9:g.113846077C>T+ p.Leu16=
-
HTR3A_000005
-
PubMed: Seneviratne 2013
-
rs33940208
Germline
-
-
-
-
-
Louise Amlie-Wolf
-?/?
1
c.50C>T
r.(?)
p.(Ala17Val)
N-Term
-
likely benign
g.113846079C>T
g.113975357C>T
c.32C>T , p.A11V
-
HTR3A_000006
-
PubMed: Hammer 2009
-
-
Germline
-
0.000 (0.000-0.010)
-
-
-
Louise Amlie-Wolf
?/?
1i
c.86-220A>T
r.(?)
p.(=)
-
-
VUS
g.113848273A>T
g.113977551A>T
-
-
HTR3A_000023
-
PubMed: Joy Lin 2014
-
rs1985242
Germline
-
0.42
-
-
-
Louise Amlie-Wolf
-?/?
2
c.115G>A
r.(?)
p.(Ala39Thr)
N-Term
-
likely benign
g.113848522G>A
g.113977800G>A
c.97G>A, p.A33T
-
HTR3A_000008
-
PubMed: Kaiser 2004
-
-
Germline
-
0.012 (242 analysed)
-AciI,BsrBI,Cac8I,FauI
-
-
Louise Amlie-Wolf
-?/?
2
c.115G>A
r.(?)
p.(Ala39Thr)
N-Term
-
likely benign
g.113848522G>A
g.113977800G>A
c.97G>A, p.A33T
-
HTR3A_000008
-
PubMed: Hammer 2009
-
-
Germline
-
0.000 (0.000-0.010)
-AciI,BsrBI,Cac8I,FauI
-
-
Louise Amlie-Wolf
-?/?
2
c.115G>A
r.(?)
p.(Ala39Thr)
N-Term
-
likely benign
g.113848522G>A
g.113977800G>A
c.97G>A , p.A33T
-
HTR3A_000008
-
PubMed: Frank 2004
-
-
Germline
-
2/96 FM (1/258 Controls)
-AciI,BsrBI,Cac8I,FauI
-
-
Louise Amlie-Wolf
-?/-?
3i
c.282+7A>C
r.(?)
p.(=)
-
-
likely benign
g.113850006A>C
g.113979284A>C
IVS3+7A>C
-
HTR3A_000010
-
PubMed: Niesler 2001b
-
rs61905785
Germline
-
6/96 (6.25%)
+CviKI_1
-
-
Louise Amlie-Wolf
-?/-?
3i
c.282+7A>C
r.(?)
p.(=)
-
-
likely benign
g.113850006A>C
g.113979284A>C
IVS3+7A>C
-
HTR3A_000010
-
PubMed: Niesler 2001b
-
-
Germline
-
5/96 (5.2%)
+CviKI_1
-
-
Louise Amlie-Wolf
-?/?
3i
c.282+7A>C
r.(?)
p.(=)
-
-
likely benign
g.113850006A>C
g.113979284A>C
IVS3+7A>C
-
HTR3A_000010
-
PubMed: Frank 2004
-
-
Germline
-
8/96 FM (5/96 Controls)
+CviKI_1
-
-
Louise Amlie-Wolf
-?/-?
3i
c.282+7A>C
r.(?)
p.(=)
-
-
likely benign
g.113850006A>C
g.113979284A>C
IVS3+7A>C
-
HTR3A_000010
-
PubMed: Niesler 2005
-
-
Germline
-
8/47 GTS; 5/48 Controls
+CviKI_1
-
-
Louise Amlie-Wolf
-?/-?
3i
c.282+7A>C
r.(?)
p.(=)
-
-
likely benign
g.113850006A>C
g.113979284A>C
IVS3+7A>C
-
HTR3A_000010
-
PubMed: Niesler 2001b
-
-
Germline
-
9/140 (6.4 %)
+CviKI_1
-
-
Louise Amlie-Wolf
?/?
3i
c.282+141G>A
r.(?)
p.(=)
-
-
VUS
g.113850140G>A
g.113979418G>A
rs2276302:c.282+141G>A
-
HTR3A_000011
-
PubMed: Rajkumar 2012
-
rs2276302
Germline
-
0.1
-BstXI,HinfI,TfiI
-
-
Louise Amlie-Wolf
?/?
3i
c.282+141G>A
r.(?)
p.(=)
-
-
VUS
g.113850140G>A
g.113979418G>A
rs2276302
-
HTR3A_000011
-
PubMed: Ducci 2009
-
rs2276302
Germline
-
0.1-0.37
-BstXI,HinfI,TfiI
-
-
Louise Amlie-Wolf
+?/.
4
c.371C>T
r.(371c>u)
p.(Pro124Leu)
-
-
likely pathogenic
g.113852013C>T
g.113981291C>T
c.353C>T (P118L)
-
HTR3A_000021
-
PubMed: Bi 2012
,
Journal: Bi 2012
-
-
Germline
?
1/67 patients
-
-
-
Zhongsheng Sun
?/?
4
c.371C>T
r.371c>u
p.(Pro124Leu)
-
-
VUS
g.113852013C>T
g.113981291C>T
c.353C>T; p.(P118L)
-
HTR3A_000021
-
personal communication
-
-
Germline
-
1/67
+BstNI,PspGI / -BsmFI,HpaII,MspI,NciI
-
-
Louise Amlie-Wolf
-?/?
4i
c.392+10G>A
r.(?)
p.(=)
-
-
likely benign
g.113852044G>A
g.113981322G>A
IVS4+10G>A
-
HTR3A_000012
-
PubMed: Hammer 2009
-
-
Germline
-
0.000 (0.000-0.018)
-HpyCH4III
-
-
Louise Amlie-Wolf
?/?
4i
c.393-143G>A
r.(?)
p.(=)
-
-
VUS
g.113853699G>A
g.113982977G>A
-
-
HTR3A_000024
-
PubMed: Ducci 2009
-
rs3737457
Germline
-
0.01-0.30
+StyI / -MnlI
-
-
Louise Amlie-Wolf
?/?
5i
c.563-56G>T
r.(?)
p.(=)
-
-
VUS
g.113856681G>T
g.113985959G>T
-
-
HTR3A_000025
-
PubMed: Joy Lin 2014
-
rs10160548
Germline
-
0.41
-AvaII,Sau96I
-
-
Louise Amlie-Wolf
-?/?
6
c.585G>T
r.(?)
p.(Leu195Phe)
N-Term
-
likely benign
g.113856759G>T
g.113986037G>T
c.567G>T , p.L189F
-
HTR3A_000013
-
PubMed: Hammer 2009
-
-
Germline
-
0.005 (0.000-0.028)
-
-
-
Louise Amlie-Wolf
-?/?
6
c.594G>A
r.(?)
p.(Leu198=)
N-Term
-
likely benign
g.113856768G>A
g.113986046G>A
c.576G>A, p.L192L; (795 G>A)
-
HTR3A_000013
-
PubMed: Kaiser 2004
-
-
Germline
-
3.8% /242
-Cac8I
-
-
Louise Amlie-Wolf
-?/?
6
c.594G>A
r.(?)
p.(Leu198=)
N-Term
-
likely benign
g.113856768G>A
g.113986046G>A
c.576G>A, p.L192L; (795 G>A)
-
HTR3A_000013
-
PubMed: Hammer 2009
-
-
Germline
-
0.020 (0.006-0.050)
-Cac8I
-
-
Louise Amlie-Wolf
-?/-?
6
c.594G>A
r.(?)
p.(Leu198=)
N-Term
-
likely benign
g.113856768G>A
g.113986046G>A
c.576G>A , p.L192L; (795 G>A)
-
HTR3A_000013
-
PubMed: Niesler 2001b
-
-
Germline
-
3/150 (2%)
-Cac8I
-
-
Louise Amlie-Wolf
-?/-?
6
c.594G>A
r.(?)
p.(Leu198=)
N-Term
-
likely benign
g.113856768G>A
g.113986046G>A
c.576G>A, p.L192L; (795 G>A)
-
HTR3A_000013
-
PubMed: Niesler 2001b
-
-
Germline
-
2/94 (2.1 %)
-Cac8I
-
-
Louise Amlie-Wolf
-?/?
6
c.594G>A
r.(?)
p.(Leu198=)
N-Term
-
likely benign
g.113856768G>A
g.113986046G>A
c.576G>A, p.L192L; (795 G>A)
-
HTR3A_000013
-
PubMed: Frank 2004
-
-
Germline
-
4/96 FM (2/94 Controls)
-Cac8I
-
-
Louise Amlie-Wolf
-?/-?
6
c.594G>A
r.(?)
p.(Leu198=)
N-Term
-
likely benign
g.113856768G>A
g.113986046G>A
c.576G>A, p.L192L; (795 G>A)
-
HTR3A_000013
-
PubMed: Niesler 2005
-
-
Germline
-
1/48 GTS; 2/47 Controls
-Cac8I
-
-
Louise Amlie-Wolf
-?/-?
6
c.594G>A
r.(?)
p.(Leu198=)
N-Term
-
likely benign
g.113856768G>A
g.113986046G>A
c.576G>A, p.L192L; (795 G>A)
-
HTR3A_000013
-
PubMed: Niesler 2001b
-
-
Germline
-
5/98 (5.1%)
-Cac8I
-
-
Louise Amlie-Wolf
-?/?
7
c.849G>A
r.(?)
p.(Lys283=)
TM2
-
likely benign
g.113857365G>A
g.113986643G>A
c.831G>A , p.K277K; (1050 G>A)
-
HTR3A_000015
-
PubMed: Hammer 2009
-
rs56232120
Germline
-
0.005 (0.001-0.019)
+MluCI / -Hpy188III
-
-
Louise Amlie-Wolf
-?/-?
7
c.849G>A
r.(?)
p.(Lys283=)
TM2
-
likely benign
g.113857365G>A
g.113986643G>A
c.831G>A, p.K277K; (1050 G>A)
-
HTR3A_000015
-
PubMed: Niesler 2001b
-
rs56232120
Germline
-
2/98 (2%)
+MluCI / -Hpy188III
-
-
Louise Amlie-Wolf
-?/-?
7
c.849G>A
r.(?)
p.(Lys283=)
TM2
-
likely benign
g.113857365G>A
g.113986643G>A
c.831G>A , p.K277K; (1050 G>A)
-
HTR3A_000015
-
PubMed: Niesler 2001b
-
rs56232120
Germline
-
2/94 (2.1%)
+MluCI / -Hpy188III
-
-
Louise Amlie-Wolf
-?/?
7
c.849G>A
r.(?)
p.(Lys283=)
TM2
-
likely benign
g.113857365G>A
g.113986643G>A
c.831G>A , p.K277K; (1050 G>A)
-
HTR3A_000015
-
PubMed: Frank 2004
-
rs56232120
Germline
-
21/96 FM (74/310 Controls)
+MluCI / -Hpy188III
-
-
Louise Amlie-Wolf
-?/-?
7
c.849G>A
r.(?)
p.(Lys283=)
TM2
-
likely benign
g.113857365G>A
g.113986643G>A
c.831G>A, p.K277K; (1050 G>A)
-
HTR3A_000015
-
PubMed: Niesler 2005
-
rs56232120
Germline
-
2/48 GTS; 2/47 Controls
+MluCI / -Hpy188III
-
-
Louise Amlie-Wolf
-?/-?
7
c.849G>A
r.(?)
p.(Lys283=)
TM2
-
likely benign
g.113857365G>A
g.113986643G>A
c.831G>A , p.K277K; (1050 G>A)
-
HTR3A_000015
-
PubMed: Niesler 2001b
-
rs56232120
Germline
-
6/142 (4.2%)
+MluCI / -Hpy188III
-
-
Louise Amlie-Wolf
+?/+?
8
c.1049G>A
r.(?)
p.(Arg350His)
LIL
-
association
g.113857661G>A
g.113986939G>A
c.1031G>A , p.R344H; (1250 G>A)
-
HTR3A_000016
-
PubMed: Niesler 2001
-
rs35815285
Germline
-
1/560 (0.002)
+HpyCH4V,SfaNI / -HgaI,Tsp45I
-
-
Louise Amlie-Wolf
+?/?
8i
c.1156+118G>A
r.(?)
p.(=)
-
-
association
g.113857886G>A
g.113987164G>A
IVS8+118G>A
-
HTR3A_000018
-
PubMed: Anderson 2009
-
rs1150220
Germline
-
0.21
-BstAPI,MwoI
-
-
Louise Amlie-Wolf
+?/+?
9
c.1190C>G
r.(?)
p.(Pro397Arg)
LIL
-
association
g.113860220C>G
g.113989498C>G
c.1172C>G, p.P391R; (1391 C>G)
-
HTR3A_000019
-
PubMed: Niesler 2001
-
-
Germline
-
1/716 (0.0015)
+BsaHI,HgaI / -AvaII,EcoO109I,NlaIV,PpuMI,Sau96I
-
-
Louise Amlie-Wolf
-?/?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
likely benign
g.113860425A>G
g.113989703A>G
c.1377A>G, p.L459L; (1596 A>G)
-
HTR3A_000020
-
PubMed: Kaiser 2004
-
rs1176713
Germline
-
34.5%/242
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
-?/?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
likely benign
g.113860425A>G
g.113989703A>G
c.1377A>G, p.L459L; (1596 A>G)
-
HTR3A_000020
-
PubMed: Hammer 2009
-
rs1176713
Germline
-
0.210 (0.156-0.273)
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
-?/-?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
likely benign
g.113860425A>G
g.113989703A>G
c.1377A>G; (1596 A>G)
-
HTR3A_000020
-
PubMed: Niesler 2001b
-
rs1176713
Germline
-
22/98 (22.4 %)
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
-?/-?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
likely benign
g.113860425A>G
g.113989703A>G
c.1377A>G, p.L459L; (1596 A>G)
-
HTR3A_000020
-
PubMed: Niesler 2001b
-
rs1176713
Germline
-
74/310 (23.9%)
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
-?/?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
likely benign
g.113860425A>G
g.113989703A>G
c.1377A>G, p.L459L; (1596 A>G)
-
HTR3A_000020
-
PubMed: Frank 2004
-
rs1176713
Germline
-
-
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
-?/-?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
likely benign
g.113860425A>G
g.113989703A>G
c.1377A>G, p.L459L; (1596 A>G)
-
HTR3A_000020
-
PubMed: Niesler 2005
-
rs1176713
Germline
-
14/48 GTS; 69/155 Controls
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
-?/-?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
likely benign
g.113860425A>G
g.113989703A>G
c.1377A>G , p.L459L; (1596 A>G)
-
HTR3A_000020
-
PubMed: Niesler 2001b
-
rs1176713
Germline
-
130/716 (18.15%)
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
-?/?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
likely benign
g.113860425A>G
g.113989703A>G
c.1377A>G, p.L459L; (1596 A>G)
-
HTR3A_000020
-
PubMed: Gu 2008
-
rs1176713
Germline
-
-
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
?/?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
VUS
g.113860425A>G
g.113989703A>G
rs1176713: NM_000869.5:c.1395A>G; NM_001161772.2:c.1332A>G; NM_213621.3:c.1491A>G NP_000860.2:p.Leu465=;NP_001155244.1:p.Leu444=; NP_998786.2:p.Leu497=
-
HTR3A_000020
-
PubMed: Xu 2012
-
rs1176713
Germline
-
0.273
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
?/?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
VUS
g.113860425A>G
g.113989703A>G
c.1377A>G, p.L459L; (1596 A>G)
-
HTR3A_000020
-
PubMed: Rüffert 2009
-
rs1176713
Germline
-
0.226
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
?/?
9
c.1395A>G
r.(?)
p.(Leu465=)
TM4
-
VUS
g.113860425A>G
g.113989703A>G
rs1176713 :p.Leu465=
-
HTR3A_000020
-
PubMed: Ducci 2009
-
rs1176713
Germline
-
0.23-0.35
-BfaI,BmtI,NheI
-
-
Louise Amlie-Wolf
10 per page
25 per page
50 per page
100 per page
250 per page
500 per page
1000 per page
Legend
How to query
Powered by
LOVD v.3.0
Build 28d
LOVD software ©2004-2023
Leiden University Medical Center